Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Baron

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Archives of Dermatology|February 15, 2002
Persistent nodule on the noseJonathan A Baron, John Raines, Jerry Bangert, et al.
Practical Radiation Oncology|July 6, 2024
Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell LymphomaJonathan A Baron, Christopher M Wright, Alexandra D Dreyfuss, et al.
Advances in Radiation Oncology|December 19, 2022
Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee CollaborationJonathan A Baron, Christopher M Wright, Russell Maxwell, et al.
Advances in Radiation Oncology|November 24, 2022
Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?Christopher M Wright, Alexandra D Dreyfuss, Jonathan A Baron, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2021
Palliative Radiotherapy for Diffuse Large B-cell LymphomaChristopher M Wright, Antony I Koroulakis, Jonathan A Baron, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 24, 2026
Safety of Concurrent Systemic Therapy and Total Skin Electron Therapy in Cutaneous T-Cell LymphomaJonathan A Baron, Leah Cohen, Monica Chelius, et al.
Clinical and Translational Radiation Oncology|January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapyNikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
International Journal of Radiation Oncology, Biology, Physics|May 25, 2020
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell LymphomaChristopher M Wright, Michael J LaRiviere, Jonathan A Baron, et al.
Blood Advances|April 9, 2025
Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cells for B-Cell Lymphomas: An ILROG Multicenter StudyNikhil Yegya-Raman, John P Plastaras, Christopher M Wright, et al.
Blood Advances|April 14, 2026
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analysesJamie E Flerlage, Dennis A Eichenauer, Michael Fuchs, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Archives of Dermatology|February 15, 2002
Persistent nodule on the noseJonathan A Baron, John Raines, Jerry Bangert, et al.
Practical Radiation Oncology|July 6, 2024
Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell LymphomaJonathan A Baron, Christopher M Wright, Alexandra D Dreyfuss, et al.
Advances in Radiation Oncology|December 19, 2022
Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee CollaborationJonathan A Baron, Christopher M Wright, Russell Maxwell, et al.
Advances in Radiation Oncology|November 24, 2022
Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?Christopher M Wright, Alexandra D Dreyfuss, Jonathan A Baron, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2021
Palliative Radiotherapy for Diffuse Large B-cell LymphomaChristopher M Wright, Antony I Koroulakis, Jonathan A Baron, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 24, 2026
Safety of Concurrent Systemic Therapy and Total Skin Electron Therapy in Cutaneous T-Cell LymphomaJonathan A Baron, Leah Cohen, Monica Chelius, et al.
Clinical and Translational Radiation Oncology|January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapyNikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
International Journal of Radiation Oncology, Biology, Physics|May 25, 2020
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell LymphomaChristopher M Wright, Michael J LaRiviere, Jonathan A Baron, et al.
Blood Advances|April 9, 2025
Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cells for B-Cell Lymphomas: An ILROG Multicenter StudyNikhil Yegya-Raman, John P Plastaras, Christopher M Wright, et al.
Blood Advances|April 14, 2026
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analysesJamie E Flerlage, Dennis A Eichenauer, Michael Fuchs, et al.
Pageof 1